The Cooper Companies, Inc. $COO Shares Acquired by IFP Advisors Inc

IFP Advisors Inc lifted its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 943.4% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 9,443 shares of the medical device company’s stock after buying an additional 8,538 shares during the period. IFP Advisors Inc’s holdings in Cooper Companies were worth $774,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. Bell Investment Advisors Inc boosted its stake in shares of Cooper Companies by 106.3% during the third quarter. Bell Investment Advisors Inc now owns 425 shares of the medical device company’s stock worth $29,000 after buying an additional 219 shares during the period. CYBER HORNET ETFs LLC acquired a new stake in shares of Cooper Companies during the second quarter worth about $36,000. True Wealth Design LLC boosted its stake in shares of Cooper Companies by 484.8% during the fourth quarter. True Wealth Design LLC now owns 462 shares of the medical device company’s stock worth $38,000 after buying an additional 383 shares during the period. Cromwell Holdings LLC boosted its stake in shares of Cooper Companies by 128.8% during the fourth quarter. Cromwell Holdings LLC now owns 485 shares of the medical device company’s stock worth $40,000 after buying an additional 273 shares during the period. Finally, Board of the Pension Protection Fund acquired a new stake in shares of Cooper Companies during the fourth quarter worth about $41,000. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Price Performance

Shares of NASDAQ:COO opened at $62.55 on Monday. The company has a quick ratio of 0.79, a current ratio of 1.34 and a debt-to-equity ratio of 0.22. The company has a market cap of $12.20 billion, a P/E ratio of 30.97, a PEG ratio of 1.61 and a beta of 0.89. The Cooper Companies, Inc. has a 52 week low of $58.89 and a 52 week high of $89.83. The company has a 50-day moving average price of $66.92 and a 200 day moving average price of $75.18.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings data on Thursday, March 5th. The medical device company reported $1.10 EPS for the quarter, beating analysts’ consensus estimates of $1.03 by $0.07. The firm had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.02 billion. Cooper Companies had a net margin of 9.67% and a return on equity of 10.34%. The firm’s revenue was up 6.2% compared to the same quarter last year. During the same quarter last year, the firm earned $0.92 earnings per share. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. Research analysts predict that The Cooper Companies, Inc. will post 4.62 earnings per share for the current year.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on COO shares. Rothschild & Co Redburn downgraded shares of Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 target price for the company. in a research note on Wednesday, March 4th. William Blair upgraded shares of Cooper Companies to a “strong-buy” rating in a research note on Friday, January 30th. Wall Street Zen upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating in a research note on Saturday, February 28th. Citigroup reduced their price objective on shares of Cooper Companies from $88.00 to $87.00 and set a “neutral” rating for the company in a research report on Friday, March 6th. Finally, Needham & Company LLC raised their price objective on shares of Cooper Companies from $99.00 to $101.00 and gave the company a “buy” rating in a research report on Friday, March 6th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $90.79.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.